GLP1R and type 2 diabetes mellitus: Second, patients with both asthma and type 2 diabetes and with a mean BMI of 39.5 ± 8.6 kg/m2 that were prescribed GLP-1R agonists exhibited fewer asthma exacerbations as compared to patients prescribed other classes of diabetic medications [134].